Efficacy and tolerability of long-acting risperidone in patients previously treated with opal atypical antipsychotics

被引:0
|
作者
Schreiner, A
Moeller, HJ
机构
[1] Janssen Cilag Neuss, Neuss, Germany
[2] Univ Munich, Dept Psychiat, Munich, Germany
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
下载
收藏
页码:96 / 97
页数:2
相关论文
共 50 条
  • [41] Patients with schizophrenia previously stabilized on conventional depot antipsychotics experience significant clinical improvements following treatment with long-acting risperidone
    Lasser, RA
    Bossie, CA
    Gharabawi, GM
    Turner, M
    EUROPEAN PSYCHIATRY, 2004, 19 (04) : 219 - 225
  • [42] Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Fu, Dong-Jing
    Ma, Yi-Wen
    Hulihan, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 341 - 350
  • [43] Experience with out-patients treated with long-acting injectable risperidone
    Madera, P. M. Holgado
    Martin, J. Diez
    Vazquez, E. Bermudez
    Mateos, R. Lopez
    EUROPEAN PSYCHIATRY, 2007, 22 : S155 - S156
  • [44] Effectiveness and tolerability outcomes of risperidone long-acting injection compared to conventional depot antipsychotics in a Canadian psychiatric hospital
    Snaterse, M
    Welch, R
    Chue, P
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S254 - S255
  • [45] Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone
    Tadger, Shelly
    Baruch, Yehuda
    Barak, Yoram
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (06) : 1245 - 1250
  • [46] Risperidone Long-Acting Injection: Safety and Efficacy in Elderly Patients with Schizophrenia
    Catalan, Rosa
    Penades, Rafael
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2011, 3 : 95 - 105
  • [47] Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
    Lasser, R
    Bossie, CA
    Gharabawi, G
    Eerdekens, M
    Nasrallah, HA
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 83 (2-3) : 263 - 275
  • [48] Comparison of oral atypical Antipsychotics to a long-acting injectable atypical antipsychotic in patients with bipolar disorder
    Binder, C
    Fallu, A
    Yatham, LN
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 203S - 203S
  • [49] Hyperprolactinemia in psychotic patients treated in monotherapy with long-acting injectable antipsychotics
    Bonete Llacer, Jose Maria
    Martinez Hortelano, Alicia
    Richart Albelda, Begona
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2019, 23 (03) : 189 - 193
  • [50] Audit of extrapyramidal symptoms in patients treated with long-acting injectable antipsychotics
    Khan, A.
    Mustafa, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S532 - S533